Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Boots expects pharmacy funding to return to ‘normal levels’ next year

Boots’ senior management expect the ongoing contract negotiations to result in funding returning to “normal levels” next year, C+D has learned.

Discussing the multiple’s latest finances in a conference call last week (June 27) – in which he also discussed plans to close 200 low-performing branches – Walgreens Boots Alliance co-chief operating officer Alex Gourlay said Boots’ parent company is “pretty convinced there’s been underfunding” for the UK’s community pharmacies “in the last period”.

“Working within…the Pharmaceutical Services Negotiating Committee (PSNC), we’re now debating that with the government in a positive way,” Mr Gourlay said, referring to the ongoing negotiations for a new funding contract.

“Of course, we can’t make any further comments until that negotiation is complete,” he added.

Chief financial officer James Kehoe also sounded optimistic, explaining he “expects an improvement” in funding by the final three months of 2019, before a return “to normal levels next year”.

Minister promises ‘fair settlement’

Addressing contractors at the National Pharmacy Association conference last month (June 20), pharmacy minister Seema Kennedy said she is “committed to working with PSNC to deliver a fair [funding] settlement for NHS services”.

This settlement will “reward those pharmacies committed to delivering a wide range of health services and better quality”, Ms Kennedy added.

Do you think the funding cuts will be reversed?

Related Content


Pharmacy Manager

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts